Zheng Zeng
No. 157, Baojian Road
Harbin, China
Harbin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Prediction of EGFR mutation status and mutation sites in lung cancer based on radiomics and deep learning.
Journal: Journal of thoracic disease
Published: March 17, 2025
Cannabidiol Inhibits Epithelial Ovarian Cancer: Role of Gut Microbiome.
Journal: Journal of natural products
Published: April 11, 2024
Enterolactone and trabectedin suppress epithelial ovarian cancer synergistically via upregulating THBS1.
Journal: Phytotherapy research : PTR
Published: April 15, 2023
Trabectedin in Cancers: Mechanisms and Clinical Applications.
Journal: Current pharmaceutical design
Published: December 28, 2021
Naringenin suppresses epithelial ovarian cancer by inhibiting proliferation and modulating gut microbiota.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: November 26, 2021
LncRNA GClnc1 may contribute to the progression of ovarian cancer by regulating p53 signaling pathway.
Journal: European journal of histochemistry : EJH
Published: July 23, 2020
Suppressive activities of mangiferin on human epithelial ovarian cancer.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: January 17, 2020
Abnormal Ca2+ handling contributes to the impairment of aortic smooth muscle contractility in Zucker diabetic fatty rats.
Journal: Journal of molecular and cellular cardiology
Published: October 17, 2019
The Oncogenic Functions of Insulin-like Growth Factor 2 mRNA-Binding Protein 3 in Human Carcinomas.
Journal: Current pharmaceutical design
Published: September 23, 2019
Thrombospondin-1 as a Potential Therapeutic Target: Multiple Roles in Cancers.
Journal: Current pharmaceutical design
Published: September 20, 2019
Overexpression of IGF2BP3 as a Potential Oncogene in Ovarian Clear Cell Carcinoma.
Journal: Frontiers in oncology
Published: July 13, 2019
Main components of pomegranate, ellagic acid and luteolin, inhibit metastasis of ovarian cancer by down-regulating MMP2 and MMP9.
Journal: Cancer biology & therapy
Published: November 28, 2017
Last Updated: 09/26/2026